Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents.
Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations.
The American Journal of Cardiovascular Drugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
《American Journal of Cardiovascular Drugs》期刊已被查看: 次
此期刊被最新的JCR期刊SCIE收录
期刊官网:https://www.springer.com/40256 |
---|
期刊投稿网址:https://www.editorialmanager.com/cvda |
PubMed Central (PMC)链接 :http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1175-3277%5BISSN%5D |
通讯地:ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311 |
中国科学院《国际期刊预警名单(试行)》名单 |
2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 此期刊被最新的JCR期刊SCIE收录 |
版面费 | 审稿速度 | 收录数据库 | 是否oa | 研究方向 |
---|---|---|---|---|
>12周,或约稿 | SCIE,Scopus | No | 医学-心血管系统 |
大类学科 | 分区 | 小类学科 | Top期刊 | 综述期刊 |
---|---|---|---|---|
医学 | 4区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学 |
否 | 否 |
版本 | 按学科 | 分区 | 影响因子 |
---|---|---|---|
2023-2024年最新版 | CARDIAC & CARDIOVASCULAR SYSTEMS PHARMACOLOGY & PHARMACY |
Q2 | 2.8 |
Journal of Inclusive Postsecondary EducationJCR:0区,分类:影响因子0收录DOAJ
详情StichprobenJCR:0区,分类:影响因子0收录DOAJ
详情EManagementJCR:0区,分类:影响因子0收录DOAJ
详情Metathesis Journal of English Language Literature and TeachingJCR:0区,分类:影响因子0收录DOAJ
详情Clinical Psychology in EuropeJCR:0区,分类:影响因子0收录Scopus,DOAJ
详情Ius InkarriJCR:0区,分类:影响因子0收录DOAJ
详情Medichna nauka UkrayiniJCR:0区,分类:影响因子0收录DOAJ
详情Economics LawJCR:0区,分类:影响因子0收录DOAJ
详情